Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Sproutly Canada Inc.
(SPR:CSE; SRUTF:OTCQB)
Technological Innovation Pushes Bounds of Edible Cannabis Market (9/11/2019)
view
Celgene Corp.
(CELG:NASDAQ)
FDA Grants Orphan Drug Status to Acceleron's PAH Candidate (9/10/2019)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast and Grunenthal Partner on Lower Back Pain Cell Therapy (9/10/2019)
view
RepliCel Life Sciences Inc.
(RP:TSX.V; REPCF:OTCQB)
RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China (9/10/2019)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast Corporate Update: Analyst Call (9/9/2019)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain (9/9/2019)
view
Cesca Therapeutics Inc.
(KOOL:NASDAQ)
Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products (9/9/2019)
view
DURECT Corp.
(DRRX:NASDAQ)
DURECT Earns $10 Million Milestone Payment for Further Development of a Long-Acting Injectable HIV Investigational Product Utilizing DURECT's SABER® Technology (9/9/2019)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Strengthens Senior Executive Management Team with the Appointment of Preetam Shah, Ph.D., M.B.A., as Chief Financial Officer (9/9/2019)
view